Health Care & Life Sciences » Pharmaceuticals | Torii Pharmaceutical Co. Ltd.

Torii Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values JPY Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,133
5,258
4,056
6,373
3,030
Depreciation, Depletion & Amortization
1,089
1,457
1,339
1,174
1,040
Other Funds
677
981
2,536
1,226
203
Funds from Operations
5,545
5,734
2,858
6,323
4,276
Changes in Working Capital
5,746
793
544
26
3,983
Net Operating Cash Flow
201
4,941
3,402
6,349
8,259
Capital Expenditures
811
1,484
760
789
Sale of Fixed Assets & Businesses
25
342
101
2
Purchase/Sale of Investments
18,499
2,099
2,006
6,805
Net Investing Cash Flow
17,706
957
1,361
7,593
Cash Dividends Paid - Total
1,132
1,245
1,358
1,346
Issuance/Reduction of Debt, Net
186
335
315
198
Net Financing Cash Flow
1,319
1,582
2,289
1,546
Net Change in Cash
16,186
4,316
2,474
2,790
Free Cash Flow
841
3,846
2,902
5,820
Other Sources
-
-
15
-
Change in Capital Stock
1
2
615
1
Other Uses
7
-
-
-

About Torii Pharmaceutical Co.

View Profile
Address
Torii Nihonbashi Building
Tokyo Tokyo 103
Japan
Employees -
Website http://www.torii.co.jp
Updated 07/08/2019
Torii Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products are mainly used in the areas of renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases and allergies, active bacteria formulation (laxative), tocolysis, eclampsia and others. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.